欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/H/0735/001
药品名称L-THYROXINE SERB 200 micrograms/ml, solution for injection/infusion
活性成分
    • Levothyroxine sodium 200.0 micrograms/ml
剂型Solution for injection/infusion
上市许可持有人SERB 40 Avenue George V 75008 Paris France
参考成员国 - 产品名称France (FR)
L-THYROXINE SERB, solution injectable
互认成员国 - 产品名称
    • Germany (DE)
      L-THYROXINE SERB, Injektionslösung
    • Denmark (DK)
      Levothyroxinnatrium SERB
    • Austria (AT)
    • Netherlands (NL)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
许可日期2022/04/12
最近更新日期2025/01/24
药物ATC编码
    • H03AA01 levothyroxine sodium
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase